Clinical Trial Update: A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial registry entry describes evaluating upadacitinib's impact on spondyloarthritis outcomes in patients with active psoriatic arthritis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Psoriatic Arthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: CARE ARTHRITIS LTD. | Conditions: Psoriatic Arthritis, Spondyloarthritis, Axial | Phase 4 | Status: RECRUITING